View all results
No results
News
Events
The industry
arrow_drop_down
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Networking platforms
Newsletter
Association
arrow_drop_down
Mission and services
Members
Academy
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
ALB001
Product
prev
next
Leave a review
Bookmark
Share
Report
prev
next
Indicaton
First personalized, orally available medicine against Rheumatoid arthritis
Therapeutic indications
Inflammation
Type of product
Small molecule
Table
Phase
Discovery
Available in
EU, US, Switzerland
You may also be interested in
AUP-16 (AUP1602-C)
AUP-16 is a multi-therapy live bacterial vector for chronic wounds: Diabetic Foot, Leg & Pressure Ulcers
Phase II started
3D CoSeedis in chip Assays
Preclinical 3D Study models for oncology and neurology.
Marketed
Cadazolid
Crohn's disease
Phase II started
Cart
×
View all results
No results
Facebook
Twitter
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
VKontakte
Mail
Copy link
This site uses cookies:
Find out more.
Accept